Skip to main content
. Author manuscript; available in PMC: 2008 Dec 12.
Published in final edited form as: Am J Trop Med Hyg. 2008 Jun;78(6):892–894.

Figure 1.

Figure 1

Dihydrolate reductase (DHFR)–164 heteroduplex tracking assay of malaria isolates from clinical samples. Lanes A–D, controls (water, non-template control [NTC], wild-type DHFR-164 DNA, and mutant DHFR-164 DNA, respectively). Each clinical sample is done in duplicate: Lanes E and F, patient 1458 (0% mutant); lanes G and H, patient 1468 (0% mutant); lanes I and J, patient 1249 (32.8% mutant); lanes K and L, patient 1367 (89.4% mutant); lanes M and N, patient 1628 (20.6% mutant); lanes O and P, patient 1238 (11.4% mutant).